Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Imarc Group
Kanika Sharma
GB Nagar
Nehru Complex

Bookmark and Share
Pneumococcal Vaccine Market Report, Trends, Scope, Demand, Size and Forecast 2021 to 2026
The global pneumococcal vaccine market grew at a CAGR of around 5% during 2015 & 2020., 9/08/2021 - A latest research report by IMARC group the titled is that “Pneumococcal Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global pneumococcal vaccine market grew at a CAGR of around 5% during 2015 to 2020. Pneumococcal infections are caused by Streptococcus pneumoniae or pneumococcus bacteria, which can cause severe lung infection (pneumonia), blood infection (bacteremia), and infection in the lining of the brain and spinal cord (meningitis). Children in the age group of 2-5 years and geriatric individuals are the most at-risk population for pneumococcal infections. The pneumococcal vaccine market share stimulates the immune system and prevents the spread of infection, thereby eliminating the need for hospitalization and reducing the fatality rate.

Get a sample copy of this Report:

Market Trends:

The rising parental concerns towards the high prevalence of pneumococcal infection in infants are propelling the demand for pneumococcal vaccines. Furthermore, the growing geriatric population who are more prone to chronic respiratory diseases is also augmenting the market growth. Additionally, the increasing consumption of cigarettes, snugs, cigars, hookah, etc., has further led to the rising incidences of severe lung diseases, thereby driving the global market. Additionally, the emergence of the Pneumococcal Conjugate Vaccine (PCV) for immunizing infants will continue to bolster the market growth in the coming years.

View Full Report with TOC & List of Figure:

Competitive Landscape with key players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being.

Astellas Pharma Inc.

GlaxoSmithKline Plc.

Merck & Co. Inc.

Panacea Biotec Ltd.

Pfizer Inc.

Sanofi S.A.

Serum Institute of India Pvt Ltd

Walvax Biotechnology Co. Ltd.

Pneumococcal Vaccine Market Segmentation:

Our report has categorized the market based on region, vaccine type, product type, distribution channel and end user.

Market Breakup by Vaccine Type:

Pneumococcal Conjugate Vaccine

Pneumococcal Polysaccharide Vaccine

Market Breakup by Product Type:

Prevnar 13


Pneumovax 23

Market Breakup by Distribution Channel:

Distribution Partner Companies

Non-Governmental Organizations (NGO)

Government Authorities

Market Breakup by End User:



About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Contact US:


30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2021 Proserve Technology, Inc.